Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Novavax climbs 9% after clinical trial shows the firm's COVID-19 vaccine is 90% effective

Business Insider - 14 Jun 2021 15:54
Novavax climbs 9% after clinical trial shows the firm's COVID-19 vaccine is 90% effective The company aims to file for FDA approval of NVX-CoV2373 in the third quarter of 2021 and is continuing to study the COVID-19 vaccine in adolescents.
Full Article at Business Insider

More Business News
11
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard